DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current molecular medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1566524013666131203101405PMID 24295492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer

  2013cited by this paper
• Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer

  2013cited by this paper
• Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance

  2013cited by this paper
• Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer

  2013cited by this paper
• Different methylation and MicroRNA expression pattern in male and female familial breast cancer

  2013cited by this paper
• MicroRNAs in human cancer.

  2013cited by this paper
• MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes

  2012cited by this paper
• Oncosuppressive role of p53‐induced miR‐205 in triple negative breast cancer

  2012cited by this paper
• Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene

  2012cited by this paper
• Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer

  2012cited by this paper
• Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese

  2012cited by this paper
• Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer

  2012cited by this paper
• Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients

  2012cited by this paper
• Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients

  2012cited by this paper
• Dysregulation of MicroRNAs in cancer

  2012cited by this paper
• HOX gene methylation status analysis in patients with hereditary breast cancer

  2012cited by this paper
• High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients.

  2012cited by this paper
• The updated biology of hypoxia‐inducible factor

  2012cited by this paper
• The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians

  2012cited by this paper
• Analysis of serum genome-wide microRNAs for breast cancer detection.

  2012cited by this paper
• MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

  2012cited by this paper
• RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development

  2012cited by this paper
• miRNA expression profiling for identification of potential breast cancer biomarkers

  2012cited by this paper
• BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex

  2012cited by this paper
• MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells

  2012cited by this paper
• A new role for miR-182 in DNA repair.

  2011cited by this paper
• MicroRNA-101-mediated Akt activation and estrogen-independent growth

  2011cited by this paper
• MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

  2011cited by this paper
• Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers

  2011cited by this paper
• Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer

  2011cited by this paper
• MicroRNA miR‐335 is crucial for the BRCA1 regulatory cascade in breast cancer development

  2011cited by this paper
• MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

  2011cited by this paper
• Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy.

  2011cited by this paper
• Global DNA methylation levels in girls with and without a family history of breast cancer

  2011cited by this paper
• Methylated genes in breast cancer

  2011cited by this paper
• Characterization of extracellular circulating microRNA

  2011cited by this paper
• miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.

  2011cited by this paper
• miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer

  2011cited by this paper
• Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumors

  2011cited by this paper
• CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer

  2011cited by this paper
• Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients.

  2010cited by this paper
• Basal-like breast cancer displays distinct patterns of promoter methylation

  2010cited by this paper
• Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.

  2010cited by this paper
• microRNAs in cancer: from bench to bedside.

  2010cited by this paper
• MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU

  2010cited by this paper
• Breast Cancer Epigenetics: From DNA Methylation to microRNAs

  2010cited by this paper
• Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

  2010cited by this paper
• Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease

  2010cited by this paper
• Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer

  2010cited by this paper
• Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin

  2010cited by this paper
• Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

  2010cited by this paper
• A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk

  2010cited by this paper
• Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers

  2010cited by this paper
• Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer

  2009cited by this paper
• microRNA-205 regulates HER3 in human breast cancer.

  2009cited by this paper
• MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness

  2009cited by this paper
• Novel genetic variants in microRNA genes and familial breast cancer

  2009cited by this paper
• Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes

  2009cited by this paper
• MiR-34, SIRT1, and p53: The feedback loop

  2009cited by this paper
• The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

  2009cited by this paper
• miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

  2009cited by this paper
• MicroRNA function in cancer: oncogene or a tumor suppressor?

  2009cited by this paper
• Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors

  2008cited by this paper
• A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer.

  2008cited by this paper
• BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype

  2008cited by this paper
• MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦

  2008cited by this paper
• Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer

  2008cited by this paper
• MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer*

  2008cited by this paper
• miRBase: tools for microRNA genomics

  2007cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2007cited by this paper
• Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.

  2007cited by this paper
• Wwox and Ap2gamma expression levels predict tamoxifen response.

  2007cited by this paper
• Triple negative tumours: a critical review

  2007cited by this paper
• Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families

  2007cited by this paper
• BRCA1 dysfunction in sporadic basal-like breast cancer

  2007cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant.

  2006cited by this paper
• Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

  2006cited by this paper
• Lack of Germ-Line Promoter Methylation in BRCA1-Negative Families with Familial Breast Cancer

  2006cited by this paper
• Basal-like breast cancer and the BRCA1 phenotype

  2006cited by this paper
• Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene.

  2005cited by this paper
• BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients.

  2005cited by this paper
• Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

  2005cited by this paper
• High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

  2003cited by this paper
• Distinct Genetic and Epigenetic Changes in Medullary Breast Cancer

  2003cited by this paper
• SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.

  2002cited by this paper
• DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.

  2001cited by this paper
• Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

  2001cited by this paper
• Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.

  2000cited by this paper
• Circulating DNA in plasma or serum.

  2000cited by this paper

• Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs

  2024cites this paper
• Transcriptomic era of cancers in females: new epigenetic perspectives and therapeutic prospects.

  2024cites this paper
• Role of ctDNA in Breast Cancer

  2022cites this paper
• Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression

  2022cites this paper
• CRISPR/Cas9-mediated activation of CDH1 suppresses metastasis of breast cancer in rats

  2021cites this paper
• Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer

  2021cites this paper
• DNA methylation variations in familial female and male breast cancer

  2021cites this paper
• Potency of Combination of Fucoidan Microsphere and MiRNA-200b as Therapy in Chemoresistant Breast Cancer

  2020cites this paper
• DNMT1-mediated methylation inhibits microRNA-214-3p and promotes hair follicle stem cell differentiate into adipogenic lineages

  2020cites this paper
• THE ROLE OF MICRORNA-200C IN CHEMORESISTANT BREAST CANCER

  2020influential citation
• Expresión tumoral de BRCA1 y resultados clínicos en pacientes uruguayas diagnosticadas de cáncer de mama antes de los 40 años

  2020cites this paper
• Prognostic value of genome-wide DNA methylation patterns in noncoding miRNAs and lncRNAs in uveal melanomas

  2019cites this paper
• Potensi mikrosfer kombinasi fukoidan dan mirna-200c sebagai inovasi penatalaksanaan kanker payudara kemoresisten

  2019cites this paper
• Periodontal Disease and Breast Cancer: A Meta-Analysis of 1,73,162 Participants

  2018cites this paper
• Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis.

  2018cites this paper
• Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells

  2017cites this paper
• Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis

  2017cites this paper
• Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.

  2017cites this paper
• Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.

  2016cites this paper
• LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer

  2016cites this paper
• Expresión de BRCA1 en lesiones benignas y malignas de la mama

  2016influential citation
• Regulatory mechanisms of microRNA expression

  2016cites this paper
• BRCA1 expression in benign and malignant breast lesions.

  2016cites this paper
• miRNAs in the of Diagnosis and Treatment of Cardiovascular Diseases

  2015cites this paper
• DNA methylation study of fetus genome through a genome-wide analysis

  2014cites this paper